Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 3

3(60.0%)

N/A

2(40.0%)

5Total

Phase 3(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04588311Phase 3Recruiting

ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Role: collaborator

NCT02568722Not ApplicableCompleted

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Role: collaborator

NCT06471972Recruiting

Biomarkers After Out-of-hospital Cardiac Arrest- a STEPCARE Substudy

Role: collaborator

NCT02735707Phase 3Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Role: collaborator

NCT03133377Phase 3Completed

Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation

Role: collaborator

NCT05298982Enrolling By Invitation

The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))

Role: collaborator

NCT02552732Not ApplicableTerminated

Nasal High Flow Therapy 30 Day Readmission Study

Role: collaborator

All 7 trials loaded